SEC Comment Letter for Mawson Infrastructure Group Inc. (MIGI) (CIK 0001218683) (BGDE) — Nov 30, 2018
Mawson Infrastructure Group Inc. (MIGI) (CIK 0001218683)
Date: Nov. 30, 2018 · CIK: 0001218683 · Accession: 0000000000-18-036818
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228516
Letter
November 30, 2018 Or Eisenberg Acting Chief Executive Officer and Chief Financial Officer Wize Pharma, Inc. 24 Hanagar Street Hod Hasharon, Israel Re:Wize Pharma, Inc. Registration Statement on Form S-1 Filed November 21, 2018 File No. 333-228516 Dear Mr. Eisenberg: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Gregory Sichenzia, Esq.
Show Raw Text
November 30, 2018
Or Eisenberg
Acting Chief Executive Officer and Chief Financial Officer
Wize Pharma, Inc.
24 Hanagar Street
Hod Hasharon, Israel
4527708
Re:Wize Pharma, Inc.
Registration Statement on Form S-1
Filed November 21, 2018
File No. 333-228516
Dear Mr. Eisenberg:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Gregory Sichenzia, Esq.